Renee D. Gala
VP-Finance, Theravance Biopharma, Inc.
Companies
- Jazz PharmaceuticalsChief executive officer Aug 11, 2025 to now1
- DexcomBoard member Mar 10, 2025 to now2
- Jazz PharmaceuticalsPresident Nov 14, 2023 to now3
- Jazz PharmaceuticalsChief operating officer Nov 14, 2023 to Mar 7, 20253
- Gossamer Bio, Inc.Board member Feb 7, 2019 to Jun 9, 20234
- Jazz PharmaceuticalsChief financial officer Mar 18, 2020 to May 19, 20235
- Theravance Biopharma, Inc.Chief financial officer Feb 9, 2015 to Nov 21, 20186
- Corcept TherapeuticsBoard member Jun 28, 2016 to Aug 22, 20187
- Theravance Biopharma, Inc.VP-Finance May 14, 2014 to Aug 22, 20148
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Jazz Pharmaceuticals JAZZ143,394 shares9$29.7M at $207.05Sep 8, 2026
Dexcom DXCM12,486 shares10$1.1M at $86.09May 28, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 8, 2026Sold 2,000 shares at $243.03 of Jazz Pharmaceuticals9
- Sep 8, 2026Shares withheld for tax 1,967 shares at $246.81 of Jazz Pharmaceuticals9
- Jun 30, 2026Shares withheld for tax 4,835 shares at $237.72 of Jazz Pharmaceuticals11
- Jun 3, 2026Gift 600 shares of Jazz Pharmaceuticals12
- May 28, 2026Granted 5,605 shares of Dexcom10
- Mar 5, 2026Shares withheld for tax 7,065 shares at $188.69 of Jazz Pharmaceuticals13
- Feb 26, 2026Granted 44,465 shares of Jazz Pharmaceuticals14
- Jan 16, 2026Shares withheld for tax 5,371 shares at $171.16 of Jazz Pharmaceuticals15
- Jan 16, 2026Granted 12,741 shares of Jazz Pharmaceuticals15
- Dec 5, 2025Shares withheld for tax 80 shares at $166.91 of Jazz Pharmaceuticals16
- Aug 7, 2025Granted 18,808 shares of Jazz Pharmaceuticals17
- May 8, 2025Granted 5,074 shares of Dexcom18
- May 8, 2025Granted 1,161 shares of Dexcom19
- Mar 6, 2025Granted 5,720 shares of Dexcom20
- Mar 5, 2025Returned to company 5,704 shares at $138.95 of Jazz Pharmaceuticals21
- Feb 27, 2025Granted 11,555 shares of Jazz Pharmaceuticals22
- Feb 27, 2025Granted 23,111 shares of Jazz Pharmaceuticals22
- Jan 17, 2025Shares withheld for tax 3,300 shares at $122.62 of Jazz Pharmaceuticals23
- Jan 17, 2025Granted 7,741 shares of Jazz Pharmaceuticals23
- Dec 5, 2024Shares withheld for tax 80 shares at $123.45 of Jazz Pharmaceuticals24
- Apr 5, 2024Shares withheld for tax 1,736 shares at $115.21 of Jazz Pharmaceuticals25
- Mar 5, 2024Shares withheld for tax 3,622 shares at $117.53 of Jazz Pharmaceuticals26
- Mar 1, 2024Granted 19,916 shares of Jazz Pharmaceuticals27
- Jan 17, 2024Shares withheld for tax 3,204 shares at $119.13 of Jazz Pharmaceuticals28
- Jan 17, 2024Granted 7,079 shares of Jazz Pharmaceuticals28
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARDexcom, Board member
- 3SEC EDGARJazz Pharmaceuticals, President
- 4SEC EDGARGossamer Bio, Inc., Board member
- 5
- 6
- 7SEC EDGARCorcept Therapeutics, Board member
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Jul 2, 2026
- 12SEC EDGARForm 4 filed Jun 5, 2026
- 13SEC EDGARForm 4 filed Mar 9, 2026
- 14SEC EDGARForm 4 filed Mar 2, 2026
- 15SEC EDGARForm 4 filed Jan 21, 2026
- 16SEC EDGARForm 4 filed Dec 9, 2025
- 17SEC EDGARForm 4 filed Aug 11, 2025
- 18SEC EDGARForm 4 filed May 12, 2025
- 19SEC EDGARForm 4 filed Jul 7, 2025
- 20SEC EDGARForm 4 filed Mar 10, 2025
- 21SEC EDGARForm 4 filed Mar 7, 2025
- 22SEC EDGARForm 4 filed Mar 3, 2025
- 23SEC EDGARForm 4 filed Jan 22, 2025
- 24SEC EDGARForm 4 filed Dec 9, 2024
- 25SEC EDGARForm 4 filed Apr 9, 2024
- 26SEC EDGARForm 4 filed Mar 7, 2024
- 27SEC EDGARForm 4 filed Mar 5, 2024
- 28SEC EDGARForm 4 filed Jan 19, 2024